Review Article
Efficacy and Safety of Abatacept in Patients With Rheumatoid Arthritis and No Prior Treatment With Biologics
Eficacia y seguridad de abatacept en pacientes con artritis reumatoide sin tratamiento biológico previo
Read
7756
Timeswas read the article
2466
Total PDF
5290
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 4 | 0 | 4 |
| 2025 5 | 114 | 48 | 162 |
| 2025 4 | 80 | 34 | 114 |
| 2025 3 | 85 | 34 | 119 |
| 2025 2 | 68 | 33 | 101 |
| 2025 1 | 80 | 35 | 115 |
| 2024 12 | 39 | 25 | 64 |
| 2024 11 | 53 | 57 | 110 |
| 2024 10 | 29 | 24 | 53 |
| 2024 9 | 38 | 14 | 52 |
| 2024 8 | 63 | 36 | 99 |
| 2024 7 | 39 | 34 | 73 |
| 2024 6 | 53 | 28 | 81 |
| 2024 5 | 46 | 28 | 74 |
| 2024 4 | 52 | 16 | 68 |
| 2024 3 | 43 | 29 | 72 |
| 2024 2 | 50 | 31 | 81 |
| 2024 1 | 47 | 28 | 75 |
| 2023 12 | 23 | 26 | 49 |
| 2023 11 | 45 | 20 | 65 |
| 2023 10 | 52 | 32 | 84 |
| 2023 9 | 95 | 33 | 128 |
| 2023 8 | 57 | 19 | 76 |
| 2023 7 | 48 | 26 | 74 |
| 2023 6 | 37 | 23 | 60 |
| 2023 5 | 45 | 14 | 59 |
| 2023 4 | 23 | 11 | 34 |
| 2023 3 | 49 | 32 | 81 |
| 2023 2 | 40 | 22 | 62 |
| 2023 1 | 20 | 25 | 45 |
| 2022 12 | 74 | 33 | 107 |
| 2022 11 | 48 | 30 | 78 |
| 2022 10 | 26 | 30 | 56 |
| 2022 9 | 39 | 26 | 65 |
| 2022 8 | 38 | 52 | 90 |
| 2022 7 | 37 | 38 | 75 |
| 2022 6 | 39 | 29 | 68 |
| 2022 5 | 27 | 50 | 77 |
| 2022 4 | 38 | 43 | 81 |
| 2022 3 | 37 | 44 | 81 |
| 2022 2 | 25 | 47 | 72 |
| 2022 1 | 37 | 31 | 68 |
| 2021 12 | 21 | 46 | 67 |
| 2021 11 | 35 | 50 | 85 |
| 2021 10 | 72 | 54 | 126 |
| 2021 9 | 50 | 38 | 88 |
| 2021 8 | 53 | 41 | 94 |
| 2021 7 | 29 | 42 | 71 |
| 2021 6 | 47 | 35 | 82 |
| 2021 5 | 54 | 30 | 84 |
| 2021 4 | 103 | 99 | 202 |
| 2021 3 | 60 | 41 | 101 |
| 2021 2 | 42 | 17 | 59 |
| 2021 1 | 36 | 14 | 50 |
| 2020 12 | 22 | 18 | 40 |
| 2020 11 | 29 | 21 | 50 |
| 2020 10 | 16 | 12 | 28 |
| 2020 9 | 30 | 16 | 46 |
| 2020 8 | 16 | 15 | 31 |
| 2020 7 | 18 | 17 | 35 |
| 2020 6 | 28 | 15 | 43 |
| 2020 5 | 24 | 22 | 46 |
| 2020 4 | 20 | 18 | 38 |
| 2020 3 | 9 | 7 | 16 |
| 2020 2 | 2 | 0 | 2 |
| 2020 1 | 13 | 0 | 13 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 5 | 0 | 5 |
| 2018 4 | 36 | 6 | 42 |
| 2018 3 | 46 | 7 | 53 |
| 2018 2 | 22 | 4 | 26 |
| 2018 1 | 22 | 4 | 26 |
| 2017 12 | 33 | 2 | 35 |
| 2017 11 | 29 | 9 | 38 |
| 2017 10 | 30 | 8 | 38 |
| 2017 9 | 42 | 6 | 48 |
| 2017 8 | 48 | 6 | 54 |
| 2017 7 | 55 | 7 | 62 |
| 2017 6 | 81 | 1 | 82 |
| 2017 5 | 73 | 16 | 89 |
| 2017 4 | 62 | 8 | 70 |
| 2017 3 | 61 | 3 | 64 |
| 2017 2 | 37 | 2 | 39 |
| 2017 1 | 52 | 6 | 58 |
| 2016 12 | 71 | 18 | 89 |
| 2016 11 | 49 | 7 | 56 |
| 2016 10 | 66 | 15 | 81 |
| 2016 9 | 91 | 6 | 97 |
| 2016 8 | 88 | 7 | 95 |
| 2016 7 | 55 | 12 | 67 |
| 2016 5 | 0 | 10 | 10 |
| 2016 4 | 2 | 0 | 2 |
| 2016 3 | 1 | 6 | 7 |
| 2016 2 | 1 | 0 | 1 |
| 2015 12 | 2 | 0 | 2 |
| 2015 10 | 0 | 17 | 17 |
| 2015 9 | 1 | 0 | 1 |
| 2015 8 | 6 | 0 | 6 |
| 2015 7 | 12 | 0 | 12 |
| 2015 6 | 46 | 7 | 53 |
| 2015 5 | 62 | 11 | 73 |
| 2015 4 | 45 | 12 | 57 |
| 2015 3 | 42 | 5 | 47 |
| 2015 2 | 41 | 9 | 50 |
| 2015 1 | 29 | 9 | 38 |
| 2014 12 | 49 | 7 | 56 |
| 2014 11 | 41 | 8 | 49 |
| 2014 10 | 46 | 9 | 55 |
| 2014 9 | 40 | 6 | 46 |
| 2014 8 | 43 | 8 | 51 |
| 2014 7 | 43 | 11 | 54 |
| 2014 6 | 39 | 10 | 49 |
| 2014 5 | 46 | 11 | 57 |
| 2014 4 | 29 | 4 | 33 |
| 2014 3 | 53 | 18 | 71 |
| 2014 2 | 32 | 11 | 43 |
| 2014 1 | 48 | 10 | 58 |
| 2013 12 | 41 | 7 | 48 |
| 2013 11 | 26 | 12 | 38 |
| 2013 10 | 51 | 11 | 62 |
| 2013 9 | 34 | 13 | 47 |
| 2013 8 | 32 | 14 | 46 |
| 2013 7 | 32 | 6 | 38 |
| 2013 6 | 35 | 12 | 47 |
| 2013 5 | 46 | 13 | 59 |
| 2013 4 | 39 | 14 | 53 |
| 2013 3 | 32 | 11 | 43 |
| 2013 2 | 29 | 16 | 45 |
| 2013 1 | 23 | 10 | 33 |
| 2012 12 | 21 | 12 | 33 |
| 2012 11 | 18 | 10 | 28 |
| 2012 10 | 14 | 6 | 20 |
| 2012 9 | 6 | 2 | 8 |
| 2012 7 | 1 | 0 | 1 |
| 2012 6 | 5 | 0 | 5 |
| 2012 4 | 6 | 0 | 6 |
| 2012 3 | 3 | 0 | 3 |
| 2012 2 | 8 | 0 | 8 |
| 2012 1 | 11 | 0 | 11 |
| 2011 12 | 4 | 0 | 4 |
Show all
